Table 6.
Open in new tab

Distribution of Shigella Serogroup Among Shigella Culture-Positive Moderate-to-Severe Diarrhea Cases in the Global Enterics Multicenter Study and Vaccine Impact on Diarrhea in Africa Study, The Gambia

Shigella SerogroupVIDA Study (2015–2018)GEMS Study (2008–2012)
Cases (n = 207), No. (%)Cases (n = 116), No. (%)
S flexneri146 (70.5)80 (69.0)
S boydii30 (14.5)7 (6.0)
S sonnei24 (11.6)24 (20.7)
S dysenteriae6 (2.9)5 (4.3)
Shigella SerogroupVIDA Study (2015–2018)GEMS Study (2008–2012)
Cases (n = 207), No. (%)Cases (n = 116), No. (%)
S flexneri146 (70.5)80 (69.0)
S boydii30 (14.5)7 (6.0)
S sonnei24 (11.6)24 (20.7)
S dysenteriae6 (2.9)5 (4.3)

Source: Kasumba et al [14].

Abbreviations: GEMS, Global Enterics Multicenter Study; VIDA, Vaccine Impact on Diarrhea in Africa.

Table 6.
Open in new tab

Distribution of Shigella Serogroup Among Shigella Culture-Positive Moderate-to-Severe Diarrhea Cases in the Global Enterics Multicenter Study and Vaccine Impact on Diarrhea in Africa Study, The Gambia

Shigella SerogroupVIDA Study (2015–2018)GEMS Study (2008–2012)
Cases (n = 207), No. (%)Cases (n = 116), No. (%)
S flexneri146 (70.5)80 (69.0)
S boydii30 (14.5)7 (6.0)
S sonnei24 (11.6)24 (20.7)
S dysenteriae6 (2.9)5 (4.3)
Shigella SerogroupVIDA Study (2015–2018)GEMS Study (2008–2012)
Cases (n = 207), No. (%)Cases (n = 116), No. (%)
S flexneri146 (70.5)80 (69.0)
S boydii30 (14.5)7 (6.0)
S sonnei24 (11.6)24 (20.7)
S dysenteriae6 (2.9)5 (4.3)

Source: Kasumba et al [14].

Abbreviations: GEMS, Global Enterics Multicenter Study; VIDA, Vaccine Impact on Diarrhea in Africa.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close